← Back
Data updated: Mar 10, 2026
WATSON PHARMS TEVA
Pharmaceuticals
WATSON PHARMS TEVA is a generic drug manufacturer with 6 FDA-approved products.
1987
Since
6
Drugs
-
Trials
14
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
RIFAMPIN 2025-07-25
Labeling
RIFAMPIN 2025-05-06
Labeling
RIFAMPIN 2025-05-06
Labeling
RIFAMPIN 2025-04-03
Labeling
RIFAMPIN 2024-06-12
Labeling
RIFAMPIN 2024-06-12
Labeling
RIFAMPIN 2024-06-12
Labeling
RIFAMPIN 2024-06-12
Labeling
RIFAMPIN 2024-06-12
Labeling
RIFAMPIN 2024-06-12
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Discontinued (4)
Company Info
- First Approval
- 1987-01-29
- Latest
- 2022-04-29
- Applications
- 9